reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

BioNexus Gene Lab Corp

BGLC · Nasdaq

1 reporting failure in the last 12 months

Companies at this level ended the following year delisted, bankrupt, restated or silent 9.2% of the time, against 4.0% for companies with a clean record.

$5Mpublic float
2026-03-31most recent failure

Score over time

0123202220232024202520262022-01-01 · score 12021-05-17 filed late (10-Q) · accounts not ready2022-04-01 · score 12021-05-17 filed late (10-Q) · accounts not ready2022-07-01 · score 12022-04-01 filed late (10-K) · accounts not ready2022-10-01 · score 12022-04-01 filed late (10-K) · accounts not ready2023-01-01 · score 12022-04-01 filed late (10-K) · accounts not ready2023-04-01 · score 12022-04-01 filed late (10-K) · accounts not ready2023-10-01 · score 12023-08-14 filed late (10-Q) · auditor2024-01-01 · score 22023-11-14 filed late (10-Q) · auditor2023-08-14 filed late (10-Q) · auditor2024-04-01 · score 32024-03-28 filed late (10-K) · accounts not ready2023-11-14 filed late (10-Q) · auditor2023-08-14 filed late (10-Q) · auditor2024-07-01 · score 32024-03-28 filed late (10-K) · accounts not ready2023-11-14 filed late (10-Q) · auditor2023-08-14 filed late (10-Q) · auditor2024-10-01 · score 22024-03-28 filed late (10-K) · accounts not ready2023-11-14 filed late (10-Q) · auditor2025-01-01 · score 22024-11-14 filed late (10-Q) · complex accounting2024-03-28 filed late (10-K) · accounts not ready2025-04-01 · score 22025-03-31 filed late (10-K) · accounts not ready2024-11-14 filed late (10-Q) · complex accounting2025-07-01 · score 22025-03-31 filed late (10-K) · accounts not ready2024-11-14 filed late (10-Q) · complex accounting2025-10-01 · score 32025-08-14 filed late (10-Q) · accounts not ready2025-03-31 filed late (10-K) · accounts not ready2024-11-14 filed late (10-Q) · complex accounting2026-01-01 · score 22025-08-14 filed late (10-Q) · accounts not ready2025-03-31 filed late (10-K) · accounts not ready2026-04-01 · score 22026-03-31 filed late (10-K)2025-08-14 filed late (10-Q) · accounts not ready2026-07-01 · score 22026-03-31 filed late (10-K)2025-08-14 filed late (10-Q) · accounts not ready2026-10-01 · score 12026-03-31 filed late (10-K)

Hover or tap a dot to see the filings behind that score.

Why they said they were late

NARRATIVE As previously disclosed, the Company undertook enhanced review of transactions in the 12 month period ended December 31, 2025 due to potential lapses in governance procedures as identified. As a result, the Company is unable to file by the prescribed due date without unreasonable effort or expense and expects to file on or before the fifteenth calendar day following the original due date, pursuant to Rule 12b-25(b)

NT 10-K, filed 2026-03-31

What it filed

2026-03-31filed late (10-K) SEC →

NARRATIVE As previously disclosed, the Company undertook enhanced review of transactions in the 12 month period ended December 31, 2025 due to potential lapses in governance procedures as identified. As a result, the Company is unable to file by the prescribed due date without unreasonable effort or expense and expects to file on or before the fifteenth calendar day following the original due date, pursuant to Rule 12b-25(b)

2025-08-14filed late (10-Q)accounts not ready SEC →

NARRATIVE The Company appointed a new Chief Financial Officer during the quarter ended June 30, 2025. The related transition of financial reporting responsibilities has required additional time to complete the preparation and review of the Company’s Quarterly Report on Form 10-Q. As a result, the Company is unable to file by the prescribed due date without unreasonable effort or expense and expects to file on or before the fifth calendar day following the original due date, pursuant to Rule 12b-25(b)

2025-03-31filed late (10-K)accounts not ready SEC →

NARRATIVE The Company has expended a considerable amount of time and effort with its Special Shareholder Meeting in an effort to effect a reverse split of its common stock which has yet to be completed. As a result, the Company’s Form 10-K could not be timely filed without unreasonable effort or expense

2024-11-14filed late (10-Q)complex accounting SEC →

NARRATIVE BioNexus Gene Lab Corp. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the three months ended September 30, 2024 (the “Quarterly Report”) by the November 14, 2024 filing date due to a delay experienced by the Registrant in completing its financial statements and other disclosures in the Quarterly Report, as a result of the complexity of recent transactions. As a result, the Registrant is still in the process of compiling the required information to complete the Quarterly Report, and reviewing its disclosures to be incorporated in the Quarterly Report. The Registrant anticipates that it will file the Quarterly Report no later than the fifth calendar day following the prescribed filing date

2024-03-28filed late (10-K)accounts not ready SEC →

NARRATIVE Bionexus Gene Lab Corp. (the “ Company ”) is filing this Form 12b-25 to report that it is unable to file its Annual Report on Form 10-K for the period ended December 31, 2023 within the prescribed time period without unreasonable effort or expense because the financial statements could not be completed in time to timely file. The Company will file the Form 10-K by the extension date

2023-11-14filed late (10-Q)auditor SEC →

NARRATIVE BioNexus Gene Lab Corp. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the three months ended September 30, 2023 (the “Quarterly Report”) by November 14, 2023 filing date applicable to smaller reporting companies due to a delay experienced by the Registrant in completing its financial statements and other disclosures in the Quarterly Report. As a result, the Registrant is still in the process of compiling the required information to complete the Quarterly Report, and its independent registered public accounting firm requires additional time to complete its review of the financial statements for the three months ended September 30, 2023, to be incorporated in the Quarterly Report. The Registrant anticipates that it will file the Quarterly Report no later than the fifth calendar day following the prescribed filing date

2023-08-14filed late (10-Q)auditor SEC →

NARRATIVE BioNexus Gene Lab Corp. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the three months ended June 30, 2023 (the “Quarterly Report”) by June 30, 2023 filing date applicable to smaller reporting companies due to a delay experienced by the Registrant in completing its financial statements and other disclosures in the Quarterly Report. As a result, the Registrant is still in the process of compiling the required information to complete the Quarterly Report, and its independent registered public accounting firm requires additional time to complete its review of the financial statements for the three months ended June 30, 2023, to be incorporated in the Quarterly Report. The Registrant anticipates that it will file the Quarterly Report no later than the fifth calendar day following the prescribed filing date

2022-04-01filed late (10-K)accounts not ready SEC →

Bionexus Gene Lab Corp. (the “ Company ”) is filing this Form 12b-25 to report that it is unable to file its Annual Report on Form 10-K for the period ended December 31, 2021 within the prescribed time period without unreasonable effort or expense because the financial statements could not be completed in time to timely file. The Company will file the Form 10-K by the extension date

2021-05-17filed late (10-Q)accounts not ready SEC →

Bionexus Gene Lab Corp. (the “ Company ”) is filing this Form 12b-25 to report that it is unable to file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 within the prescribed time period without unreasonable effort or expense because the financial statements could not be completed in time to timely file. The Company will file the Form 10-Q by the extension date

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com